AGP Executive Report
Last update: 5 hours agoCold-Chain Stress Test: The NHS is preparing to move a new gene-therapy gel, Vyjuvek, which must be stored at ultra-cold temperatures and tracked precisely to keep patients safe. Medicaid Transparency Push: As work requirements loom, California and other states are pushing to publicly name big employers with workers on Medicaid, arguing it’s about fairness and shifting costs to taxpayers. Workforce Strain in Public Care: Malaysia reports 3,511 medical officers quit its public system from 2023–2025, with officials pointing to pay and career incentives as the main retention tools. Cybersecurity in Clinics: Australia’s Partnered Health says a major hack may have exposed patient records across its GP and skin cancer network, and patients are being contacted. Generic vs Innovator Spending: Malaysia’s MOH says generics dominated 2025 medicine procurement (RM3.01B; 77.88%), disputing claims that innovator spending was higher. Shelter Expansion: Canada’s federal funding helped expand Medicine Hat’s Phoenix Safe House, adding bedrooms and capacity for women in crisis. Pharma Deal/Access: Septa Pharmaceuticals acquired CeeNU (lomustine) from Bristol Myers Squibb to strengthen Canada oncology supply. Clinical Pipeline Updates: Tonix published new mpox clade findings in Journal of Virology, while aTyr shared Phase 3 sarcoidosis subgroup data and aTyr/aTyr-linked programs continue advancing.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.